VIVENDI
European Company with a Management Board and a Supervisory Board and a share capital of €6,522,975,915.50 Head Office: 42 avenue de Friedland - 75380 PARIS CEDEX 08 - FRANCE
IMPORTANT NOTICE: READERS ARE STRONGLY ADVISED TO READ THE IMPORTANT DISCLAIMERS AT THE END OF THIS FINANCIAL REPORT.
Wednesday March 03, 2021
KEY CONSOLIDATED FINANCIAL DATA FOR THE LAST FIVE YEARS ............................................................................................................. 4
I- 2020 FINANCIAL REPORT ...................................................................................................................................................................................... 6
1 EARNINGS ANALYSIS: GROUP AND BUSINESS SEGMENTS ................................................................................................................................ 6
1.1 CONSOLIDATED STATEMENT OF EARNINGS ............................................................................................................................................................ 7
1.2 ANALYSIS OF THE CONSOLIDATED STATEMENT OF EARNINGS .................................................................................................................................. 7
1.3 ANALYSIS OF REVENUES AND OPERATING RESULTS BY BUSINESS SEGMENT ............................................................................................................. 11
2 LIQUIDITY AND CAPITAL RESOURCES ............................................................................................................................................................... 20
2.1 LIQUIDITY AND EQUITY PORTFOLIO ........................................................................................................................................................................ 20
2.2 CASH FLOW FROM OPERATIONS ANALYSIS ............................................................................................................................................................ 22
2.3 ANALYSIS OF INVESTING AND FINANCING ACTIVITIES .............................................................................................................................................. 24
3 OUTLOOK ........................................................................................................................................................................................................ 25
4 FORWARD-LOOKING STATEMENTS ................................................................................................................................................................. 25
5 OTHER DISCLAIMERS ...................................................................................................................................................................................... 26
II- APPENDIX TO THE FINANCIAL REPORT ......................................................................................................................................................... 27
1 QUARTERLY REVENUES BY BUSINESS SEGMENT ..................................................................................................................................................... 27
III- AUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2020 ............................................. 29
STATUTORY AUDITORS' REPORT ON THE CONSOLIDATED FINANCIAL STATEMENTS ......................................................................... 29
CONSOLIDATED STATEMENT OF EARNINGS .................................................................................................................................................... 34
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME ...................................................................................................................... 35
CONSOLIDATED STATEMENT OF FINANCIAL POSITION ................................................................................................................................ 36
CONSOLIDATED STATEMENT OF CASH FLOWS ............................................................................................................................................... 37
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY .............................................................................................................................. 38
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS .......................................................................................................................... 40
NOTE 1 | ACCOUNTING POLICIES AND VALUATION METHODS ...................................................................................................................................... 40 |
NOTE 2 | MAJOR EVENTS ...................................................................................................................................................................................... 59 |
NOTE 3 | COVID-19 PANDEMIC IMPACTS ................................................................................................................................................................ 61 |
NOTE 4 | SEGMENT DATA ...................................................................................................................................................................................... 62 |
NOTE 5 | EBIT ...................................................................................................................................................................................................... 67 |
NOTE 6 | FINANCIAL CHARGES AND INCOME ............................................................................................................................................................ 68 |
NOTE 7 | INCOME TAXES ........................................................................................................................................................................................ 69 |
NOTE 8 | EARNINGS PER SHARE .............................................................................................................................................................................. 74 |
NOTE 9 | CHARGES AND INCOME DIRECTLY RECOGNIZED IN EQUITY ............................................................................................................................. 74 |
NOTE 10 | GOODWILL .............................................................................................................................................................................................. 75 |
NOTE 11 | CONTENT ASSETS AND COMMITMENTS ..................................................................................................................................................... 79 |
NOTE 12 | LEASES ................................................................................................................................................................................................... 81 |
NOTE 13 | INVESTMENTS IN EQUITY AFFILIATES .......................................................................................................................................................... 82 |
NOTE 14 | FINANCIAL ASSETS .................................................................................................................................................................................. 84 |
NOTE 15 | NET WORKING CAPITAL ............................................................................................................................................................................ 85 |
NOTE 16 | CASH POSITION ....................................................................................................................................................................................... 86 |
NOTE 17 | EQUITY ................................................................................................................................................................................................... 87 |
NOTE 18 | PROVISIONS ............................................................................................................................................................................................ 89 |
NOTE 19 | EMPLOYEE BENEFITS ................................................................................................................................................................................ 90 |
NOTE 20 | SHARE-BASED COMPENSATION PLANS ...................................................................................................................................................... 95 |
NOTE 21 | BORROWINGS AND OTHER FINANCIAL LIABILITIES AND FINANCIAL RISK MANAGEMENT .................................................................................... 99 |
NOTE 22 | CONSOLIDATED CASH FLOW STATEMENT ............................................................................................................................................... 104 |
NOTE 23 | RELATED PARTIES ................................................................................................................................................................................. 105 |
NOTE 24 | CONTRACTUAL OBLIGATIONS AND OTHER COMMITMENTS ......................................................................................................................... 109 |
NOTE 25 | LITIGATION ........................................................................................................................................................................................... 113 |
NOTE 26 | MAJOR CONSOLIDATED ENTITIES OR ENTITIES ACCOUNTED FOR UNDER THE EQUITY METHOD ........................................................................ 123 |
NOTE 27 | STATUTORY AUDITORS FEES ................................................................................................................................................................... 125 |
NOTE 28 | AUDIT EXEMPTIONS .............................................................................................................................................................................. 125 |
NOTE 29 | SUBSEQUENT EVENTS ............................................................................................................................................................................ 126 |
Wednesday March 03, 2021
Key consolidated financial data for the last five years
Preliminary comments:
As a reminder, in 2019, Vivendi applied a new accounting standard:
• IFRS 16 - Leases: in accordance with IFRS 16, the impact of the change of accounting standard was recorded in the opening balance sheet as of January 1, 2019. In addition, Vivendi applied this change of accounting standard to the Statement of Financial Position, Statement of Earnings and Statement of Cash Flows in 2019; therefore, the data relative to prior years is not comparable. For a detailed description of these changes, please refer to Notes 1.1, 1.3.5.7 and 12 to the Consolidated Financial Statements for the year ended December 31, 2020.
As a reminder, in 2018, Vivendi applied two new accounting standards:
• IFRS 15 - Revenues from Contracts with Customers: in accordance with IFRS 15, as from 2017, Vivendi applied this change of accounting standard to revenues. The data presented below with respect to fiscal year 2016 are historical and therefore not restated; and
• IFRS 9 - Financial Instruments: in accordance with IFRS 9, as from 2018, Vivendi applied this change of accounting standard to the Statement of Earnings and Statement of Comprehensive Income restating its opening balance sheet as of January 1, 2018; therefore, the data relative to prior years in this report is not comparable.
Year ended December 31,
2020 | 2019 | 2018 | 2017 | 2016 | |
Consolidated data | |||||
Revenues | 16,090 | 15,898 | 13,932 | 12,518 | 10,819 |
Income from operations (a) | 1,815 | 1,719 | 1,439 | 1,098 | 853 |
Adjusted earnings before interest and income taxes (EBITA) (a) | 1,627 | 1,526 | 1,288 | 969 | 724 |
Earnings before interest and income taxes (EBIT) | 1,468 | 1,381 | 1,182 | 1,018 | 887 |
Earnings attributable to Vivendi SE shareowners | 1,440 | 1,583 | 127 | 1,216 | 1,256 |
of which earnings from continuing operations attributable to Vivendi SE | 1,440 | 1,583 | 127 | 1,216 | 1,236 |
shareowners | |||||
Adjusted net income (a) | 1,228 | 1,741 | 1,157 | 1,300 | 755 |
Net Cash Position/(Financial Net Debt) (a) | (4,953) | (4,064) | 176 | (2,340) | 1,231 |
Total equity | 16,431 | 15,575 | 17,534 | 17,866 | 19,612 |
of which Vivendi SE shareowners' equity | 15,759 | 15,353 | 17,313 | 17,644 | 19,383 |
Cash flow from operations (CFFO) (a) | 696 | 903 | 1,126 | 989 | 729 |
Cash flow from operations after interest and income tax paid (CFAIT) (a) | 548 | 567 | 822 | 1,346 | 341 |
Financial investments | (1,640) | (2,284) | (694) | (3,685) | (4,084) |
Financial divestments | 360 | 1,068 | 2,303 | 976 | 1,971 |
Dividends paid by Vivendi SE to its shareholders | 690 | 636 | 568 | 499 | 2,588 |
Purchases/(sales) of Vivendi SE's treasury shares | 2,157 | 2,673 | - | 203 | 1,623 |
Per share data | |||||
Weighted average number of shares outstanding | 1,140.7 | 1,233.5 | 1,263.5 | 1,252.7 | |
Earnings attributable to Vivendi SE shareowners per share | 1.26 | 1.28 | 0.10 | 0.97 | |
Adjusted net income per share | 1.08 | 1.41 | 0.92 | 1.04 | |
Number of shares outstanding at the end of the period (excluding treasury shares) | 1,092.8 | 1,170.6 | 1,268.0 | 1,256.7 | |
Equity per share, attributable to Vivendi SE shareowners | 14.42 | 13.12 | 13.65 | 14.04 | |
Dividends per share paid | 0.60 | 0.50 | 0.45 | 0.40 | |
In millions of euros, number of shares in millions, data per share in euros. |
(b)
1,272.6
0.99
0.59
1,259.5
15.39
2.00 (b)
a. The non-GAAP measures of Income from operations, EBITA, Adjusted net income, Net Cash Position (or Financial Net Debt), Cash flow from operations (CFFO) and Cash flow from operations after interest and income tax paid (CFAIT) should be considered in addition to, and not as a substitute for, other GAAP measures of operating and financial performance as presented in the Consolidated Financial Statements and the related Notes, or as described in this Financial Report. Vivendi considers these to be relevant indicators of the group's operating and financial performance. Each of these indicators is defined in the appropriate section of this Financial Report. In addition, it should be noted that other companies may have definitions and calculations for these indicators that differ from those used by Vivendi, thereby affecting comparability. Furthermore, as of December 31, 2020, in the context of the COVID-19 pandemic, Vivendi had not changed the definition of these indicators, which are therefore comparable to fiscal year 2019.
b. With respect to fiscal year 2015, Vivendi paid an ordinary dividend of €3 per share, i.e., an aggregate dividend payment of €3,951 million. This amount included €2,588 million paid in 2016 (€1,318 million for the second interim dividend of €1 per share and €1,270 million representing the balance of €1 per share) and €1,363 million paid in 2015 (first interim dividend of €1 per share).
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Vivendi SA published this content on 03 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 March 2021 14:48:03 UTC.